title: Antiplatelet and Anticoagulation Therapy in Structural Heart Disease Interventions Beyond TAVI.
abstract: Transcatheter interventions for structural heart disease represent an emerging field in interventional cardiology. Undoubtedly, there is an absolute necessity for antiplatelet and/or anticoagulation treatment prior, during and post such interventions. However, currently administered regimens are mainly based in expert consensus recommendations. In the present review we aim to summarize data regarding anti platelet and/or anticoagulation treatment in the following transcatheter structural heart interventions: left atrial appendage closure, atrial septal defect closure, patent foramen oval closure, paravalvular leak closure.
authors.affiliation: 13 Astypaleas, Anoixi, Attiki 14569, Greece.
authors.forename: Manolis
authors.initials: M
authors.lastname: Vavuranakis
authors.affiliation: Department of Cardiovascular Medicine, Ohio State University, Columbus, OH, United States.
authors.forename: Konstantinos Dean
authors.initials: KD
authors.lastname: Boudoulas
authors.affiliation: Department of Cardiology, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: Ourania
authors.initials: O
authors.lastname: Katsarou
authors.affiliation: Department of Cardiology, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: Dimitrios A
authors.initials: DA
authors.lastname: Vrachatis
authors.affiliation: Department of Cardiology, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: Konstantinos I
authors.initials: KI
authors.lastname: Kalogeras
authors.affiliation: Department of Cardiology, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: Theodore G
authors.initials: TG
authors.lastname: Papaioannou
authors.affiliation: Department of Cardiology, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: Gerasimos
authors.initials: G
authors.lastname: Siasos
authors.affiliation: Department of Cardiology, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: Evangelos
authors.initials: E
authors.lastname: Oikonomou
authors.affiliation: Department of Cardiology, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: George
authors.initials: G
authors.lastname: Lazaros
authors.affiliation: Department of Cardiology, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: Michael-Andreas
authors.initials: MA
authors.lastname: Vavuranakis
authors.affiliation: Department of Cardiology, Attikon Hospital, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: Spyridon
authors.initials: S
authors.lastname: Deftereos
authors.affiliation: Department of Cardiology, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Tousoulis
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D006331:Heart Diseases / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D065467:Transcatheter Aortic Valve Replacement
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors
keywords: ASD; LAA; NOAC; PFO; antiplatelet; coumadin; transcatheter; warfarin